Clinical Outcomes of Stent Versus Non-Stent Interventions for Symptomatic Infrainguinal Peripheral Artery Disease in the Excellence in Peripheral Artery Disease (XLPAD) Registry

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Angiosafe; Chiesi
• Grant Support/Research Contract - GE Healthcare; Novartis; Esperion; Abbott